from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1422/-

LFCtreatmentdescriptionclass of inhibitor

-1.602

Amikacinug/mL Amikacintranslation

-2.642

Cap5-10ug/mL Capreomycintranslation

-3.214

Rox10-50 ug/mL Roxithromycintranslation

-0.633

SM2-5 ug/mL Streptomycintranslation

-2.499

Tet5-10 ug/mL Tetracyclinetranslation

-0.741

Rif0.2-5ug/mL Rifampicintranscription

-0.592

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.851

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.321

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.168

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.045

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.015

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.451

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.527

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.241

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.199

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.224

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.073

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.318

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.373

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.608

KCN5-20 ug/mL Potassium cyaniderespiration

0.737

NaN30.2-2 mM Sodium aziderespiration

-0.473

Nigericin50 uM Nigericinrespiration

0.302

TRC10-150 ug/mL Triclosanrespiration

-1.168

TRZ10-25 ug/mL Thioridazinerespiration

-0.000

Valinomycin0.5-10 uM Valinomycinrespiration

0.123

ZnSO42 mM ZnSO4respiration

-0.286

menadione6-10 ug/mL Menadionerespiration

-0.308

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.026

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.430

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.030

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.023

NRP_1Non-replicating persistence stage 1dosRassociated

0.227

Amp0.2mg/mL AmpicillincellWall

-0.225

Cephalexin20-100 ug/mL CephalexincellWall

-0.075

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.275

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.066

EMB10-20 ug/mL EthambutolcellWall

-0.262

Eta12-40 ug/mL EthionamidecellWall

-0.163

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.311

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.290

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.244

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.981

BZA0.12 mg/mL BenzamidearomaticAmides

0.689

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.451

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.356

H2O24 mM hydrogen peroxideDNAdamaging

-0.421

Levo10 ug/mL LevofloxacinDNAdamaging

0.886

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.178

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.201

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.201

UVUV-irradiationDNAdamaging

-1.216

ARP41-4 ug/mL Antitubercular compound ARP4?

0.321

Antimycin12.5-50 ug/mL Antimycin A?

-0.418

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.379

PA_110-50 ug/mL Antitubercular compound PA-1?

0.193

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.796

PA8240.2-2 ug/mL PA-824?

1.358

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.650

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.274

Verapamil50 uM Verapamil?

0.119

mercaptoethanol2 mM 2-Mercaptoethanol?

0.377

methoxatin10-20 ug/mL Methoxatin?